By Steve Elliott
A Thursday press briefing via Webinar will address the need for better quality control in medical marijuana products.
The briefing, hosted by RTI International, will address the public health risks arising in this unregulated market due to factors such as:
• Product types and formulations that vary from state to state, store to store, even product to product;
• Inaccurate product labeling and marketing claims;
• Limited testing of medical marijuana products for safety and efficacy; and
• Lack of professional guidelines and governmental regulations. This places the burden on the consumers and providers to be aware of the above factors and how they affect dosing and ultimately, safety.
This briefing comes at a time when the number of medical marijuana users is on the rise in the U.S. and even presidential candidates on the campaign trail are calling for more research.
Marijuana itself, of course, is as safe as it ever was. But as big corporate money and big corporate mass production methods have come to the medicinal cannabis world, the mom-and-pop atmosphere of trust and safety which had distinguished the industry from the rest of the cut-throat economy is fading away. Production is increased by using chemical fertilizers and harsh pesticides, and those who are focused only on profit and not on healing are looking only at the bottom line.